NAMs and the Funding Frontier: How Modern Toxicology Maximizes Scientific Return on Investment

By Zachary Liebowitz | May 29th, 2025

“Funders are not only looking for scientific merit—they are also scrutinizing value and feasibility. NAMs answer all three.”

Image by ChatGPT